영상 유도 수술 장비 수요가 확대되고 있는 배경에는 수술 수술의 정확성과 환자의 예후를 향상시키는 몇 가지 기본적인 이유가 있습니다. 내비게이션, 향상된 내시경 장비 등의 기술을 통합한 이러한 시스템을 통해 수술사는 수술 중 내부 구조를 보다 정확하게 관찰할 수 있게 되어 시장은 2024년에 90억 5,000만 달러의 매출을 돌파했고, 2032년에는 약 199억 4,000만 달러의 평가액에 달할 전망입니다.
기술의 진보와 선진적 이미지 모달리티의 이용 가능성 증가가 이러한 시스템 수요를 부추기고 있습니다. 이 개발은 복잡한 치료를보다 정확하고 효율적으로 수행하므로 환자의 결과가 개선되고 입원 기간이 단축되고 시장은 2026-2032년에 CAGR 11.45%를 나타낼 것으로 전망됩니다.
영상 유도 수술 장비 시장 정의/개요
영상 유도 수술 장비(IGSE)는 수술의 정확성과 효과를 향상시키기 위해 실시간 이미지를 사용하는 최신 기술의 집합체를 말합니다. 안에 상세한 시각적 피드백을 제공합니다. IGSE는 수술 의사에게 수술 부위의 실시간 또는 가까운 이미지를 제공함으로써 복잡한 수술과 낮은 침습 수술에서 특히 중요한 보다 정확한 탐색 및 타겟팅을 가능하게 합니다.
영상 유도 수술 기술은 수술 수술의 정확성과 효과를 향상시키기 위해 현대 의료에서 매우 중요합니다. 이 기술은 실시간 이미지 양식(MRI, CT 스캔 또는 투시 검사)과 수술 기구를 결합하여 수술 부위의 상세하고 정확한 관찰을 가능하게 합니다. 주요 용도 중 하나는 신경 수술이며, 영상 유도 시스템을 통해 수술사는 복잡한 뇌 영역을 높은 정확도로 탐색 할 수 있습니다.
영상 유도 수술 기술의 미래 응용은 다양한 수술 전문 부문에서 수술의 정확성과 결과를 크게 향상시킬 것으로 기대됩니다. 고해상도 수술 중 이미지 및 실시간 3D 시각화와 같은 이미지 기술의 진보는 수술사에게 치료 중 해부학적 구성 요소의 상세하고 정확한 뷰를 제공하여 수술 수술의 방식을 변경할 것으로 예측됩니다.
노인 증가는 영상 유도 수술 장비 시장의 주요 촉진요인입니다. 나이가 들수록 수술 치료가 자주 필요한 다양한 건강 문제에 직면하기 쉽습니다. 세계보건기구(WHO)에 따르면 세계의 60세 이상 인구 비율은 2015-2050년 사이에 12%에서 22%로 거의 두 배가 될 전망입니다. 이 인구 동향은 2050년까지 60세 이상의 인구가 약 20억 명에 달하는 것에 해당합니다.
노화와 관련된 질병 증가와 낮은 침습 수술에 대한 수요가 결합되어 영상 유도 수술 장비의 사용이 증가할 가능성이 높습니다. 미국 국립 노화 실험실에 따르면 노인의 85% 이상이 적어도 하나의 만성 성 건강 문제를 갖고 있으며, 60%가 2개 이상의 문제를 겪고 있습니다. 심혈관 질환, 성형 수술 문제, 일부 악성 종양과 같은 이러한 질병의 대부분은 수술 개입이 필요합니다. 영상 유도 수술 장비는 이러한 치료에서 더 나은 정확도, 적은 침습성, 더 빠른 회복 시간 등 특히 노인 환자에게 필수적인 이점을 설명합니다.
영상 기술의 고비용은 영상 유도 수술 장비 시장의 성장을 제한할 수 있는 현저한 요인입니다. MRI, CT 스캔, 수술 중 영상 시스템과 같은 고급 영상 양식은 영상 유도 수술의 중요한 구성요소이므로 정확한 네비게이션과 수술 정밀도를 향상시킬 수 있습니다. 그러나 이러한 기술은 장비 구입, 지속적인 유지보수, 의료 종사자에게 특별한 교육의 필요성 등 비용이 많이 듭니다. 이러한 높은 가격은 건강 관리 시설, 특히 개발 도상국 및 재정의 제한된 소규모 클리닉의 도입에 큰 장애가 될 수 있습니다.
영상 유도 수술에 드는 비용은 환자에게 전가되는 경우가 많기 때문에 화상 기술의 고비용은 환자에게 영향을 미칩니다. 환자가 상당한 의료비를 부담하는 건강 관리 시스템은 혁신적인 수술 수술을 이용하기 어려워지고 합리적인 가격으로 받지 못할 수 있습니다. 저소득층과 보험 적용이 제한된 지역의 환자들은 고가의 이미징 기술을 필요로 하는 수술 자금에 대해 어려움을 겪고 보다 선진적이고 저렴한 대체 의학을 선택할 수 있습니다. 그 결과 특히 신흥국에서는 영상 유도 수술의 수락이 지연되고 시장 성장이 제한될 수 있습니다.
The growing demand for image-guided surgical equipment can be ascribed to several fundamental reasons driving improvements in surgical accuracy and patient outcomes. For starters, there has been an increased emphasis on minimally invasive surgical treatments which benefit greatly from the improved visualization afforded by image-guided devices. These systems which incorporate technologies like intraoperative imaging, real-time 3D navigation, and improved endoscopic equipment allow surgeons to observe internal structures more accurately during surgeries by enabling the market to surpass a revenue of USD 9.05 Billion valued in 2024 and reach a valuation of around USD 19.94 Billion by 2032.
Advancements in technology and the growing availability of advanced imaging modalities have fueled demand for these systems. Improvements in imaging resolution, integration with robotic surgical platforms, and the creation of portable imaging devices have all expanded the capabilities of image-guided surgery. These developments have made complex treatments more accurate and efficient resulting in better patient outcomes and shorter hospital stays by enabling the market to grow at a CAGR of 11.45 % from 2026 to 2032.
Image Guided Surgical Equipment Market: Definition/ Overview
The term "Image Guided Surgical Equipment" (IGSE) refers to a collection of modern technologies that use real-time imaging to improve the precision and effectiveness of surgery. This device combines several imaging modalities such as X-ray, MRI, CT scans, and ultrasound with surgical instruments to provide detailed visual feedback during procedures. By providing surgeons with real-time or near-real-time views of the surgical site, IGSE enables more precise navigation and targeting which is especially important in complex or minimally invasive surgeries.
Image-guided surgical technology is crucial in modern medicine because it improves surgical precision and effectiveness. This technology combines real-time imaging modalities (MRI, CT scans, or fluoroscopy) with surgical instruments to provide detailed, accurate viewing of the operative site. One major use is neurosurgery where image-guided systems allow surgeons to navigate complicated brain regions with high precision.
The future application of image-guided surgical technology is expected to greatly improve precision and results in a variety of surgical specialties. Imaging technology advancements such as high-resolution intraoperative imaging and real-time 3D visualization are projected to alter surgical practices by giving surgeons detailed, correct views of anatomical components during procedures.
The growing geriatric population is a primary driver of the image guided surgical equipment market. As people age, they become increasingly vulnerable to a variety of health problems that frequently necessitate surgical treatments. According to the World Health Organization (WHO), the share of the world's population over 60 will nearly double between 2015 and 2050 from 12% to 22%. This demographic trend equates to around 2 billion persons over the age of 60 by 2050.
The rise in age-related illnesses, combined with the demand for minimally invasive operations is likely to drive up the use of image-guided surgical equipment. According to the National Institute on Aging, over 85% of older persons have at least one chronic health issue with 60% having two or more. Many of these ailments such as cardiovascular disease, orthopedic issues, and some malignancies necessitate surgical intervention. Image-guided surgical equipment provides substantial advantages for these treatments including better precision, less invasiveness, and faster recovery times all of which are especially essential for elderly patients.
The high cost of imaging techniques is a prominent factor that may limit the growth of the image guided surgical (IGS) equipment market. Advanced imaging modalities including MRI, CT scans, and intraoperative imaging systems, are critical components of image-guided surgeries, allowing for accurate navigation and increased surgical precision. However, these technologies come at a high expense including the original equipment purchase, continuous maintenance, and the requirement for specific training for medical workers. These high prices can be a significant obstacle to the adoption of healthcare facilities, particularly those in underdeveloped countries or with small clinics with limited finances.
The high cost of imaging techniques influences patients, as the fees connected with image-guided surgeries are frequently passed on to them. In healthcare systems where patients shoulder a large amount of medical costs, innovative surgical procedures may become less accessible and affordable. Patients in lower-income categories or areas with limited insurance coverage may struggle to finance surgeries that need expensive imaging techniques leading them to choose less advanced, less expensive alternatives. This could result in slower acceptance of image-guided procedures, particularly in emerging nations limiting the market's growth.
Computed Tomography (CT) scanners dominate the global image guided surgery devices market accounting for the largest market share among various imaging modalities including ultrasound systems, magnetic resonance imaging (MRI), endoscopes, X-ray fluoroscopy, and positron emission tomography (PET). The increasing use of CT scanners in image-guided procedures can be attributed to their unequaled capacity to produce detailed cross-sectional images of the body. CT scanners are essential for identifying and treating a variety of illnesses including skeletal deformities, vascular difficulties, and cancer.
CT scanners are very popular in image-guided operations because they provide quick imaging and allow for real-time assessments during procedures. This is especially important in instances requiring fast decision-making such as in trauma or while dealing with malignancies. CT scanners generate high-resolution images that allow surgeons to accurately plan and execute surgical procedures resulting in more effective treatments and faster recovery times for patients. Furthermore, CT imaging's versatility, which allows it to be used in a variety of medical fields, including orthopedics, neurology, cardiology, and cancer, strengthens its market dominance.
The neurosurgery sector has the greatest market share in the worldwide image guided surgery (IGS) devices market and it is predicted to grow at the fastest compound annual growth rate (CAGR) over the forecast period. This dominance stems principally from the essential role that image-guided surgery plays in neurosurgical treatments. Neurosurgery frequently requires operating on exceedingly delicate and complicated structures in the brain and spinal cord where even little errors can have serious effects.
The rise in neurological ailments and diseases worldwide is a prominent factor driving the growth of the neurosurgery segment in the IGS Devices Market. The rising prevalence of illnesses including brain tumors, Parkinson's disease, and epilepsy has increased the desire for sophisticated surgical techniques with better outcomes and shorter recovery times. Furthermore, the use of these devices lowers the risk of post-operative problems since they enable more accurate targeting of problematic regions while sparing healthy tissues.
Gain Access into Image Guided Surgical Equipment Market Report Methodology
The North American image guided surgical equipment market is primarily driven by increased demand for minimally invasive procedures (MIS). This supremacy is due to the region's advanced healthcare infrastructure, strong adoption rates of cutting-edge medical technology, and growing patient preference for less intrusive operations. The aging population is an important consideration, as older people are more likely to require medical procedures.
According to the United States Census Bureau, the number of Americans aged 65 and up is expected to nearly double from 52 million in 2018 to 95 million by 2060. Furthermore, technical improvements in imaging modalities and surgical navigation systems improve the precision and efficacy of image-guided procedures. In recent years, the United States Food and Drug Administration (FDA) has approved several novel image-guided surgical systems demonstrating that this technology has a developing market.
The Asia Pacific region is seeing the highest development in the image guided surgical equipment market owing to rapid technology improvements and rising healthcare costs. This rise is being driven by several critical factors that are accelerating the adoption of innovative healthcare technology throughout the area. The increased frequency of chronic diseases as well as the aging population are major drivers of the Asia Pacific image guided surgical equipment market.
According to World Bank data, health expenditure as a proportion of GDP in East Asia and the Pacific increased from 6.4% in 2010 to 7.1% in 2019. This increased funding allows healthcare facilities to invest in cutting-edge technology such as image-guided surgical equipment. Furthermore, government attempts to improve healthcare infrastructure are having a substantial impact. For example, China's "Healthy China 2030" plan intends to modernize medical equipment in public hospitals which is expected to increase the use of new surgical technology.
The Image Guided Surgical Equipment Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.
Some of the prominent players operating in the image guided surgical equipment market include:
Brainlab
General Electric
Medrobotics Corporation
Medion
Stereotaxis, Inc.
Titan Medical Inc.
PS-Medtech
Renishaw plc.
Intuitive Surgical
Zimmer Biomet
Siemens Healthcare GmbH
Medtronic
In February 2021, Curadel Surgical Innovations Inc., a privately owned manufacturer of near-infrared fluorescent contrast agents for image-guided surgery, announced a global distribution agreement with a tier-one medical technology company after receiving FDA and EMA approvals.
In January 2021, Royal Philips, a global leader in health technology, announced advanced 3D image guidance features for its Image-Guided Therapy Mobile C-arm System - Zenition. These features improve clinical accuracy and efficiency for endovascular treatment, leading to better patient outcomes.